| Literature DB >> 33484635 |
Carrow I Wells1, David H Drewry1, Julie E Pickett1, Amelie Tjaden2, Andreas Krämer2, Susanne Müller2, Laszlo Gyenis3, Daniel Menyhart3, David W Litchfield4, Stefan Knapp2, Alison D Axtman5.
Abstract
Building on the pyrazolopyrimidine CK2 (casein kinase 2) inhibitor scaffold, we designed a small targeted library. Through comprehensive evaluation of inhibitor selectivity, we identified inhibitor 24 (SGC-CK2-1) as a highly potent and cell-active CK2 chemical probe with exclusive selectivity for both human CK2 isoforms. Remarkably, despite years of research pointing to CK2 as a key driver in cancer, our chemical probe did not elicit a broad antiproliferative phenotype in >90% of >140 cell lines when tested in dose-response. While many publications have reported CK2 functions, CK2 biology is complex and an available high-quality chemical tool such as SGC-CK2-1 will be indispensable in deciphering the relationships between CK2 function and phenotypes.Entities:
Keywords: CK2; IDG; cancer; casein kinase 2; chemical probe; crystal structure; kinase; nanoBRET; proliferation; small molecule
Mesh:
Substances:
Year: 2021 PMID: 33484635 PMCID: PMC8864761 DOI: 10.1016/j.chembiol.2020.12.013
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116